Literature DB >> 16369972

Relative incidence of agranulocytosis and aplastic anemia.

David W Kaufman1, Judith P Kelly, Surapol Issaragrisil, Joan-Ramon Laporte, Theresa Anderson, Micha Levy, Samuel Shapiro, Neal S Young.   

Abstract

Agranulocytosis and aplastic anemia are both rare, life-threatening blood dyscrasias. Agranulocytosis is mainly caused by medicines, whereas the etiology of aplastic anemia is largely unexplained. In two epidemiologic studies using the same methods, we observed a striking inverse relationship between the incidence of the two diseases in different regions, including five countries in Europe, and Israel and Thailand. The annual incidence of agranulocytosis ranged from 1.1 to 4.9 cases per million, and that of aplastic anemia, from 0.7 to 4.1 per million; the inverse correlation was consistent among the regions (R2 = 0.74). There is no clear explanation for this previously unreported pattern, but it seems unlikely to be due to methodology. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16369972     DOI: 10.1002/ajh.20489

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  15 in total

1.  Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.

Authors:  Eliane Maluf; Nelson Hamerschlak; Alexandre Biasi Cavalcanti; Alvaro Avezum Júnior; José Eluf-Neto; Roberto Passetto Falcão; Irene G Lorand-Metze; Daniel Goldenberg; Cézar Leite Santana; Daniela de Oliveira Werneck Rodrigues; Leny Nascimento da Motta Passos; Luis Gastão Mange Rosenfeld; Marimilia Pitta; Sandra Loggetto; Andreza A Feitosa Ribeiro; Elvira Deolinda Velloso; Andrea Tiemi Kondo; Erika Oliveira de Miranda Coelho; Maria Carolina Tostes Pintão; Hélio Moraes de Souza; José Rafael Borbolla; Ricardo Pasquini
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

2.  Drug-Induced Neutropenia: A Focus on Rituximab-Induced Late-Onset Neutropenia.

Authors:  Donald C Moore
Journal:  P T       Date:  2016-12

3.  [Clinical otorhinolaryngological symptoms of metamizole-induced agranulocytosis].

Authors:  T Send; S Westermann; K W G Eichhorn; M Jakob
Journal:  HNO       Date:  2015-03       Impact factor: 1.284

4.  Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia.

Authors:  José Luis Revuelta-Herrero; Raquel García-Sánchez; Javier Anguita-Velasco; Ana de Lorenzo-Pinto; Cristina Ortega-Navarro; María Sanjurjo-Sáez
Journal:  Int J Clin Pharm       Date:  2019-06-29

5.  Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis.

Authors:  Farrukh Munir; Hafiza Wajeeha Javaid; Muhammad Burhan Majeed Rana; Fatima Shaukat
Journal:  Cureus       Date:  2022-03-16

Review 6.  Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.

Authors:  Frank Peinemann; Ulrich Grouven; Nicolaus Kröger; Max Pittler; Beate Zschorlich; Stefan Lange
Journal:  Haematologica       Date:  2009-07-31       Impact factor: 9.941

7.  First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.

Authors:  Frank Peinemann; Ulrich Grouven; Nicolaus Kröger; Carmen Bartel; Max H Pittler; Stefan Lange
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

8.  Agranulocytosis Associated With Spironolactone Therapy: A Case Report.

Authors:  Adam A Fershko; Jennifer A Neely; Alejandro R Calvo
Journal:  World J Oncol       Date:  2011-10-28

9.  Agranulocytosis - Sequelae of Chronic Cocaine Use: Case Series and Literature Review.

Authors:  Roma Srivastava; Maira Rizwan; Muhammad Omer Jamil; Palaniandy Kogulan; Donna Salzman
Journal:  Cureus       Date:  2017-05-03

Review 10.  Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review.

Authors:  Frank Peinemann; Alexander Michael Labeit
Journal:  BMJ Open       Date:  2014-07-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.